Audubon-based Globus Medical has announced its acquisition of California life sciences company Nevro Corp. for $250 million ...

Globus Medical’s world is about to get a little bigger, as the orthopedic devicemaker moves to acquire Nevro and its ...

Globus Medical (NYSE:GMED) announced today that it agreed to acquire chronic pain treatment developer Nevro (NYSE:NVRO).

Globus Medical reports Q4 2024 sales of $657 million ... Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote ...

Globus Medical (GMED) also reaffirmed its guidance for 2025 net sales of $2.66B to $2.69B and non-GAAP EPS of $3.40 to $3.50. Following the merger, Globus Medical (GMED) expects 2025 net sales of ...

Globus Medical reported preliminary sales projections for 2024 of $2.52 billion, while Nevro expects revenues between $408 million to $409 million. Globus Medical's acquisition of Nevro will ...

On a stand-alone basis, Globus Medical (GMED) reaffirms guidance for 2025 net sales of $2.66B to $2.69B and fully diluted non-GAAP earnings per share range between $3.40 to $3.50; Revenue ...

Globus said it anticipates in annual net sales this year to total between $2.8 billion and $2.9 billion. Globus Medical’s financial adviser for the deal is Morgan Stanley & Co. Wyrick Robbins ...

Globus Medical announced preliminary 2024 net sales of $2.52 billion, an increase of 60.6% over prior year on an as-reported basis; and On January 13, 2025, Nevro announced preliminary 2024 ...